C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for Zentalis Pharmaceuticals in a research note issued on Wednesday, January 29th. Leerink Partnrs analyst A. Berens now ...